Reino Unido -
inglés -
MHRA (Medicines & Healthcare Products Regulatory Agency)
trihexyphenidyl 2mg tablets
kent pharma (uk) ltd - trihexyphenidyl hydrochloride - oral tablet - 2mg
Reino Unido -
inglés -
MHRA (Medicines & Healthcare Products Regulatory Agency)
trihexyphenidyl 2mg tablets
alliance healthcare (distribution) ltd - trihexyphenidyl hydrochloride - oral tablet - 2mg
Reino Unido -
inglés -
MHRA (Medicines & Healthcare Products Regulatory Agency)
trihexyphenidyl 2mg tablets
teva uk ltd - trihexyphenidyl hydrochloride - oral tablet - 2mg
Reino Unido -
inglés -
MHRA (Medicines & Healthcare Products Regulatory Agency)
trihexyphenidyl 2mg tablets
dowelhurst ltd - trihexyphenidyl hydrochloride - oral tablet - 2mg
Reino Unido -
inglés -
MHRA (Medicines & Healthcare Products Regulatory Agency)
trihexyphenidyl 2mg tablets
accord-uk ltd - trihexyphenidyl hydrochloride - oral tablet - 2mg
Reino Unido -
inglés -
MHRA (Medicines & Healthcare Products Regulatory Agency)
trihexyphenidyl 2mg tablets
phoenix healthcare distribution ltd - trihexyphenidyl hydrochloride - oral tablet - 2mg
Reino Unido -
inglés -
MHRA (Medicines & Healthcare Products Regulatory Agency)
trihexyphenidyl 2mg tablets
sigma pharmaceuticals plc - trihexyphenidyl hydrochloride - oral tablet - 2mg
Reino Unido -
inglés -
MHRA (Medicines & Healthcare Products Regulatory Agency)
trihexyphenidyl 2mg tablets
waymade healthcare plc - trihexyphenidyl hydrochloride - oral tablet - 2mg
Reino Unido -
inglés -
MHRA (Medicines & Healthcare Products Regulatory Agency)
trihexyphenidyl 2mg tablets
genesis pharmaceuticals ltd - trihexyphenidyl hydrochloride - oral tablet - 2mg
Estados Unidos -
inglés -
NLM (National Library of Medicine)
trihexyphenidyl hydrochloride tablet
state of florida doh central pharmacy - trihexyphenidyl hydrochloride (unii: ao61g82577) (trihexyphenidyl - unii:6rc5v8b7po) - this drug is indicated as an adjunct in the treatment of all forms of parkinsonism (postencephalitic, arteriosclerotic, and idiopathic). it is often useful as adjuvant therapy when treating these forms of parkinsonism with levodopa. additionally, it is indicated for the control of extrapyramidal disorders caused by central nervous system drugs such as the dibenzoxazepines, phenothiazines, thioxanthenes, and butyrophenones.